EUVIMED · CrossrefZeitschrift
Frontiers in Allergy
ISSN 2673-6101 · Frontiers Media SA
Neueste Artikel
Mustard-directed oral immunotherapy and structured oral exposure: lessons from four children
Prenatal and postnatal omega-3 supplementation for the prevention and treatment of atopic dermatitis: a systematic review of randomized controlled trials
Real-life safety of venom immunotherapy in children and adults: latent class analysis from the Adverse Events Registry
Type 2 inflammation through the lens of inborn errors of immunity
Wood smoke fire particulate matter induces eosinophilic asthma in a Sprouty2-dependent manner in mice
Case Report: A novel SERPING1 variant in a four-generation Chinese pedigree with hereditary angioedema with C1-inhibitor deficiency type 1
Nutritional considerations for alpha-gal syndrome: a mini-review
Interleukin-33 at the intersection of inflammation and repair
Pathophysiological and molecular insights into allergic conjunctivitis: an expanding analysis of immunological endotypes
Millettia speciosa reprograms the lung proteome and suppresses CCL24-driven eosinophilic inflammation in allergic asthma
The nasal-oral microbiome axis in allergic rhinitis: environmental triggers, microbial dysbiosis, and immune dysregulation
Toward personalized prediction: a multicenter machine learning model for omalizumab response duration in moderate-to-severe perennial allergic rhinitis
Two combinations of house dust mite allergens show similar performance than extracts for asthma diagnosis
EUFOREA summit in Brussels 2025: inspiring the future of allergy and respiratory care
Silent invaders: the role of MPs on epithelium inflammation and damage in airway diseases
Current challenges in allergic diseases and computational solutions towards personalized medicine
IgE, anti-IgE therapy, and regulatory T cells: new paradigms in allergic inflammation
Safety of a novel oral immunotherapy approach in preschool children with single and multiple food allergies
MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia
Symptom burden in patients with chronic rhinosinusitis with nasal polyps or global airway disease prior to biologic treatment: a qualitative study of patients' experiences
Chronic rhinosinusitis with and without nasal polyps: the state-of-the-art of current treatment strategies and future developments
Unravelling allergic rhinitis: exploring pathophysiology, advances in treatment, and future directions
Co-existence of chronic spontaneous urticaria with atopic dermatitis: clinical and immunological perspectives
Implementation of genetic diagnosis and personalized management of hereditary angioedema in a Chinese regional center: a community case study of three families
From mechanism to management: CEREMAST perspectives on the intersection of HαT and clonal mast cell disorders
The epithelial barrier: a Janus-faced regulator in allergic airway diseases from defense to inflammation
Burden of allergic rhinitis in the United Kingdom
Epithelial-derived cytokines in the pathogenesis of severe asthma
Nasal saline irrigation with azelastine-fluticasone nasal spray in moderate-to-severe persistent allergic rhinitis: a randomized controlled trial
Real-life evaluation of the effectiveness of biologics for chronic rhinosinusitis with nasal polyps in Europe: a Delphi study to define key variables for the INVENT registry
EUVIMED